T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure-Reference-Cited by-同舟云学术

T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure

Published:2017-11-22 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gröschel Carina,Sasse André,Röhrborn Charlotte,Monecke Sebastian,Didié Michael,Elsner Leslie,Kruse Vanessa,Bunt Gertrude,Lichtman Andrew H.,Toischer Karl,Zimmermann Wolfram-Hubertus,Hasenfuß Gerd,Dressel Ralf

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-16147-1.pdf

Reference57 articles.

1. Ziaeian, B. & Fonarow, G. C. Epidemiology and aetiology of heart failure. Nat. Rev. Cardiol. 13, 368–378 (2016).

2. Ahmad, T., Fiuzat, M., Felker, G. M. & O’Connor, C. Novel biomarkers in chronic heart failure. Nat. Rev. Cardiol. 9, 347–359 (2012).

3. Stephenson E., Savvatis K., Mohiddin S. A. & Marelli-Berg F. M. T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation. Br. J. Pharmacol. (2016).

4. van Linthout, S. & Tschöpe, C. Inflammation - Cause or Consequence of Heart Failure or Both? Curr. Heart Fail. Rep. 14, 251–265 (2017).

5. Torre-Amione, G. et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J. Am. Coll. Cardiol. 27, 1201–1206 (1996).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis;Expert Review of Anticancer Therapy;2024-06-16

2. Molecular Mechanism of Yangshen Maidong Decoction in the Treatment of Chronic Heart Failure based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations;Cell Biochemistry and Biophysics;2024-05-16

3. B cell-mediated antigen presentation promotes adverse cardiac remodeling in chronic heart failure;2024-05-11

4. Mechanism of fibroblast growth factor 21 in cardiac remodeling;Frontiers in Cardiovascular Medicine;2023-06-21

5. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity;Science Advances;2023-04-28